as amended, including, but not limited to, statements concerning: BioNTech’s expected revenues related to sales of BioNTech’s COVID-19 vaccine, referred to as COMIRNATY where approved for use under full or conditional marketing authorization, in territories...
Why is the FDA granting approval for a drug designed to stop COVID-19 when we know for anabsolute factthat it doesnot? The insert also confirms that the safety of Comirnaty is based ononly two studies. The first has a sample size of only 60 participants.And get this… the second...
Global Information About Pfizer‑BioNTech COVID‑19 Vaccine (also known as BNT162b2 or as COMIRNATY) The approval status of the Pfizer‑BioNTech COVID‑19 Vaccine varies worldwide. For countries where the relevant regulatory authority has not authorised the vaccine or has not authorised it...
as amended, including, but not limited to, statements concerning: BioNTech’s expected revenues related to sales of BioNTech’s COVID-19 vaccine, referred to as COMIRNATY where approved for use under full or conditional marketing authorization, in territories...
The companies plan to submit these data to the FDA and EMA for a requested amendment to the Emergency Use Authorization of BNT162b2 and the EU Conditional Marketing Authorization for COMIRNATY to expand use in adolescents 12-15 years of age as quickly as possible. All participant...
December 23, 2024 · 207 min read · BioSpace Editorial Staff Drug shortages FDA Confirms Lilly’s GLP-1s Are Not in Shortage, Gives Compounders Grace Period December 19, 2024 · 3 min read · Tristan Manalac Layoffs Novartis Cuts MorphoSys Sites in Boston, Munich, Affectin...